VRTX
Vertex Pharmaceuticals Incorporated
NASDAQ · USHealthcareBiotechnology
$486.00+0.07%
Price as of Jul 20, 2026
VRTX ownership
Vertex Pharmaceuticals Incorporated ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
13
Net (3m)
-$10.6M
Insider trades by month Buys Sells
Feb
Mar
Apr
May
Jun
Jul
Context3-month price +13.8%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 7, 2026 | McKechnie Duncanofficer: EVP, Chief Commercial Officer | Sell | 1,541 | $519.00 |
| Jul 7, 2026 | Tatsis Ouraniaofficer: EVP, Chief Reg. & Quality Off. | Sell | 1,500 | $524.99 |
| Jul 6, 2026 | Liu Joyofficer: EVP and Chief Legal Officer | Sell | 828 | $502.71 |
| Jun 30, 2026 | Bozic Carmenofficer: EVP and CMO | Sell | 596 | $482.50 |
| Jun 23, 2026 | Bozic Carmenofficer: EVP and CMO | Sell | 1,020 | $462.17 |
| Jun 17, 2026 | Bozic Carmenofficer: EVP and CMO | Sell | 4,062 | $450.00 |
| Jun 9, 2026 | Bozic Carmenofficer: EVP and CMO | Sell | 1,745 | $450.00 |
| Jun 2, 2026 | Bozic Carmenofficer: EVP and CMO | Sell | 1,974 | $450.00 |
| May 19, 2026 | Bozic Carmenofficer: EVP and CMO | Sell | 1,354 | $453.45 |
| May 19, 2026 | Bunnage Mark E.officer: EVP, Chief Scientific Officer | Sell | 33 | $453.45 |
| May 14, 2026 | Bozic Carmenofficer: EVP and CMO | Sell | 6,988 | $450.00 |
| May 5, 2026 | MCKENZIE DIANAdirector | Grant | 796 | — |
| May 5, 2026 | Bhatia Sangeeta N.director | Sell | 318 | $423.73 |
| May 5, 2026 | Schneider Jenniferdirector | Grant | 472 | — |
| May 5, 2026 | Garber Alan Mdirector | Grant | 472 | — |
| May 5, 2026 | Garber Alan Mdirector | Grant | 1,433 | $424.45 |
| May 5, 2026 | Liu Joyofficer: EVP and Chief Legal Officer | Sell | 1,104 | $425.02 |
| May 5, 2026 | CARNEY LLOYDdirector | Grant | 2,866 | $424.45 |
| May 5, 2026 | Schneider Jenniferdirector | Grant | 1,433 | $424.45 |
| May 5, 2026 | Upadhyay Suketudirector | Grant | 2,866 | $424.45 |
| May 5, 2026 | Thornberry Nancydirector | Grant | 398 | — |
| May 5, 2026 | Schneider Jenniferdirector | Grant | 796 | — |
| May 5, 2026 | Bhatia Sangeeta N.director | Grant | 943 | — |
| May 5, 2026 | Thornberry Nancydirector | Grant | 472 | — |
| May 5, 2026 | SACHS BRUCE Idirector | Grant | 2,866 | $424.45 |
| May 5, 2026 | MCKENZIE DIANAdirector | Grant | 943 | — |
| May 5, 2026 | Upadhyay Suketudirector | Grant | 796 | — |
| May 5, 2026 | Thornberry Nancydirector | Grant | 1,433 | $424.45 |
| May 5, 2026 | Lagarde Micheldirector | Grant | 2,866 | $424.45 |
| Apr 17, 2026 | SACHS BRUCE Idirector | Grant | 107 | — |
Source: VRTX SEC Form 4 filings, latest Jul 7, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their VRTX positions over the last 6 months (SEC Form 13F).
Increased
1358
New positions
380
Reduced
1207
Sold out
212
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| CAPITAL WORLD INVESTORS | Reduced | 25.5M | Feb 11, 2026 |
| CAPITAL WORLD INVESTORS | Reduced | 25.4M | May 13, 2026 |
| VANGUARD GROUP INC | Reduced | 24.1M | Jan 29, 2026 |
| BLACKROCK, INC. | Increased | 24.0M | May 13, 2026 |
| BLACKROCK, INC. | Increased | 23.8M | Feb 12, 2026 |
| CAPITAL RESEARCH GLOBAL INVESTORS | Increased | 21.1M | May 13, 2026 |
| CAPITAL RESEARCH GLOBAL INVESTORS | Increased | 17.3M | Feb 11, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 16.5M | May 15, 2026 |
| STATE STREET CORP | Increased | 11.7M | May 15, 2026 |
| STATE STREET CORP | Increased | 11.7M | Feb 13, 2026 |
| JPMORGAN CHASE & CO | Increased | 7.0M | May 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 6.1M | May 15, 2026 |
| JPMORGAN CHASE & CO | Reduced | 6.0M | Feb 11, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 6.0M | Feb 9, 2026 |
| INVESCO LTD. | Reduced | 5.3M | Jul 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.